
Full text loading...
We use cookies to track usage and preferences.I Understand
The preclinical antidiabetic and anti-obesity potential of hydrotropic solid dispersions of hesperidin and naringenin was investigated in streptozotocin [STZ]/nicotinamide [NIC]-induced diabetic rats on a high-fat diet. The hydrotropic solid dispersions showed significant glycemic control, insulin sensitivity, and lipid profiles while reducing body weight, adipose tissue mass, and inflammatory markers. These formulations showed superior efficacy over pure compounds, likely due to enhanced solubility compared to the pure drugs. Findings suggested that hesperidin and naringenin hydrotropic solid dispersions are promising agents for showing antihyperglycemic, antidyslipidemic, and cardiac function-improving potential in high-fat diet/STZ-induced type 2 diabetic rats, supporting their potential clinical application as adjunct therapies. These findings support the utility of the tested samples in clinical applications as an adjunct therapy.
Article metrics loading...
Full text loading...
References
Data & Media loading...